The era of chemotherapy, which started in the middle of the last century, has been ruled by the routine use of dose-intense protocols, based on the "maximum-tolerated dose" concept. By promoting a balance between patient's quality of life and the goal of rapidly killing as many tumour cells as possible, these protocols still play a prominent role in veterinary oncology. However, with the opening of a new millennium, metronomic chemotherapy (MC) started to be considered a possible alternative to traditional dose-intense chemotherapy. Characterized by a long-term daily administration of lower doses of cytotoxic drugs, this new modality stands out for its unique combination of effects, namely on neovascularization, immune response and tumour dormancy. This article reviews the rationale for treatment with MC, its mechanism of action and the main studies conducted in veterinary medicine, and discusses the key challenges yet to be solved.

The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field / Gaspar, T B; Henriques, J; Marconato, L; Queiroga, F L. - In: VETERINARY AND COMPARATIVE ONCOLOGY. - ISSN 1476-5829. - ELETTRONICO. - 16:1(2018), pp. 2-11. [10.1111/vco.12309]

The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field

Marconato, L;
2018

Abstract

The era of chemotherapy, which started in the middle of the last century, has been ruled by the routine use of dose-intense protocols, based on the "maximum-tolerated dose" concept. By promoting a balance between patient's quality of life and the goal of rapidly killing as many tumour cells as possible, these protocols still play a prominent role in veterinary oncology. However, with the opening of a new millennium, metronomic chemotherapy (MC) started to be considered a possible alternative to traditional dose-intense chemotherapy. Characterized by a long-term daily administration of lower doses of cytotoxic drugs, this new modality stands out for its unique combination of effects, namely on neovascularization, immune response and tumour dormancy. This article reviews the rationale for treatment with MC, its mechanism of action and the main studies conducted in veterinary medicine, and discusses the key challenges yet to be solved.
2018
The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field / Gaspar, T B; Henriques, J; Marconato, L; Queiroga, F L. - In: VETERINARY AND COMPARATIVE ONCOLOGY. - ISSN 1476-5829. - ELETTRONICO. - 16:1(2018), pp. 2-11. [10.1111/vco.12309]
Gaspar, T B; Henriques, J; Marconato, L; Queiroga, F L
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/702219
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 21
social impact